首页> 外国专利> Suppression of endogenous immunoglobulin expression in transgenic non-human animals expressing humanized or human antibodies

Suppression of endogenous immunoglobulin expression in transgenic non-human animals expressing humanized or human antibodies

机译:在表达人源化或人源抗体的转基因非人动物中内源性免疫球蛋白表达的抑制

摘要

The invention provides a novel approach for suppression of endogenous antibody expression in non-human transgenic animals genetically engineered to express one or several human or humanized immunoglobulin transloci. Polyclonal or one or several monoclonal antibodies specific for endogenous IgM and/or IgE heavy and/or light chains are administered to the transgenic animals such that B-cells expressing their endogenous immunoglobulin are depleted and consequently expression of endogenous immunoglobulin is suppressed. Alternatively endogenous immunoglobulin expression may be inhibited through the expression of transgenes encoding such antibodies, including antibody fragments. This method allows the dominant expression of transloci coding for humanized or human antibodies in the blood, milk and eggs of transgenic animals.
机译:本发明提供了一种新的方法,用于抑制非人转基因动物中内源性抗体表达,所述动物经基因工程改造以表达一个或多个人或人源化免疫球蛋白易位。向转基因动物施用对内源性IgM和/或IgE重链和/或轻链具有特异性的多克隆或一种或几种单克隆抗体,使得表达其内源性免疫球蛋白的B细胞被耗尽,因此内源性免疫球蛋白的表达被抑制。备选地,内源免疫球蛋白的表达可以通过编码此类抗体(包括抗体片段)的转基因的表达来抑制。这种方法可以在转基因动物的血液,牛奶和鸡蛋中显性表达编码人源化或人源抗体的易位子。

著录项

  • 公开/公告号US2004158880A1

    专利类型

  • 公开/公告日2004-08-12

    原文格式PDF

  • 申请/专利权人 BUELOW ROLAND;VAN SCHOOTEN WIM;

    申请/专利号US20040774208

  • 发明设计人 WIM VAN SCHOOTEN;ROLAND BUELOW;

    申请日2004-02-05

  • 分类号A01K67/027;

  • 国家 US

  • 入库时间 2022-08-21 23:22:42

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号